Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort.

Neurobiol Aging 2019 02 22;74:234.e9-234.e15. Epub 2018 Sep 22.

Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address:

NIPA1 (nonimprinted in Prader-Willi/Angelman syndrome 1) mutations are known to cause hereditary spastic paraplegia type 6, a neurodegenerative disease that phenotypically overlaps to some extent with amyotrophic lateral sclerosis (ALS). Previously, a genomewide screen for copy number variants found an association with rare deletions in NIPA1 and ALS, and subsequent genetic analyses revealed that long (or expanded) polyalanine repeats in NIPA1 convey increased ALS susceptibility. We set out to perform a large-scale replication study to further investigate the role of NIPA1 polyalanine expansions with ALS, in which we characterized NIPA1 repeat size in an independent international cohort of 3955 patients with ALS and 2276 unaffected controls and combined our results with previous reports. Meta-analysis on a total of 6245 patients with ALS and 5051 controls showed an overall increased risk of ALS in those with expanded (>8) GCG repeat length (odds ratio = 1.50, p = 3.8×10). Together with previous reports, these findings provide evidence for an association of an expanded polyalanine repeat in NIPA1 and ALS.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01974580183033
Publisher Site
http://dx.doi.org/10.1016/j.neurobiolaging.2018.09.012DOI Listing
February 2019
30 Reads

Publication Analysis

Top Keywords

international cohort
8
expanded polyalanine
8
lateral sclerosis
8
nipa1 als
8
patients als
8
previous reports
8
als
8
nipa1 repeat
8
amyotrophic lateral
8
nipa1
6
expansions als
4
als characterized
4
analyses revealed
4
polyalanine expansions
4
nipa1 polyalanine
4
characterized nipa1
4
repeat size
4
cohort 3955
4
3955 patients
4
independent international
4

Similar Publications